Prescription Drug Abuse Prevention and Treatment Act of 2013

The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348

Client expense: $520,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Implementation of addiction treatment issues. Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity Public Law 111-148, Patient Protection and Affordable Care Act, Implementation of addiction treatment issues. Prescription Drug abuse issues. S.2092/H.R.4288, Opioid Overdose Reduction Act of 2014, Access to Naloxone S.348/H.R.672, Prescription Drug Abuse Prevention and Treatment Act of 2013, Prescription drug abuse related issues S.2504, A bill to address prescription opioid and heroin abuse, generally S.2645, TREAT Act, Addiction treatment and recovery issues; 100 patient limit for buprenorphine prescribers S.2839, Comprehensive Addiction and Recovery Act of 2014, Prescription opioid abuse and heroin use treatment issues Addition to #17 below: Center for Substance Abuse Treatment (CSAT)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse, (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621); Counterfeit Drugs; Importation of Prescription Drugs

Client expense: $257,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348

Client expense: $390,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 348/H.R. 672, Prescription Drug Abuse Prevention and Treatment Act- A bill to provide for increased Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths. (entire bill)

Client expense: $350,000 · Firm income: Not reported

Government targets: Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715, S. 2549)

Client expense: $361,413 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715, S. 2549)

Client expense: $361,413 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Implementation of addiction treatment issues. Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity Public Law 111-148, Patient Protection and Affordable Care Act, Implementation of addiction treatment issues. Prescription Drug abuse issues. S.2092/H.R.4288, Opioid Overdose Reduction Act of 2014, Access to Naloxone 100 patient limit for buprenorphine prescribers S.348/H.R.672, Prescription Drug Abuse Prevention and Treatment Act of 2013, Prescription drug abuse related issues S.2504, A bill to address prescription opioid and heroin abuse, generally S.2645, TREAT Act, Addiction treatment and recovery issues S.2839, Comprehensive Addiction and Recovery Act of 2014, Prescription opioid abuse and heroin use treatment issues Addition to #17 below: Center for Substance Abuse Treatment (CSAT)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348

Client expense: $680,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 348/H.R. 672, Prescription Drug Abuse Prevention and Treatment Act- A bill to provide for increased Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths. (entire bill)

Client expense: $380,000 · Firm income: Not reported

Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2437), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse, (S. 348, S. 1277, H.R. 4069, H.R. 4709), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $233,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Implementation of addiction treatment issues. Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity Public Law 111-148, Patient Protection and Affordable Care Act, Implementation of addiction treatment issues. Prescription Drug abuse issues. S.2092/H.R.4288, Opioid Overdose Reduction Act of 2014, Access to Naloxone 100 patient limit for buprenorphine prescribers S.348/H.R.672, Prescription Drug Abuse Prevention and Treatment Act of 2013, Prescription drug abuse related issues S.2504, A bill to address prescription opioid and heroin abuse, Prescription drug abuse related issues Addition to #17 below: Center for Substance Abuse Treatment (CSAT)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348

Client expense: $420,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069), Hydrocodone Rescheduling (H.R. 1285, S. 621, and NPRM Docket No. DEA-389), Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Safe Prescribing Act (HR 1285/S 621) Stop Oxy Abuse Act (HR 1366) Prescription Drug Abuse Prevention and Treatment Act (HR 672/S 348) Access to Substance Abuse Treatment Act of 2013 (HR 2130)

Client expense: $26,518 · Firm income: Not reported

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $267,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 348/H.R. 672, Prescription Drug Abuse Prevention and Treatment Act

Client expense: $260,000 · Firm income: Not reported

Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348

Client expense: $730,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE

S. 348/H.R. 672: Prescription Drug Abuse Prevention and Treatment Act

Client expense: $330,000 · Firm income: Not reported

Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

**see addendum pageImportation of prescription drugs (H.R. 3715) Drug Abuse (S. 348, S. 1277) Hydrocodone Rescheduling (H.R. 1285, S. 621) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R.1919, H.R. 2186; H.R. 3204 - PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Dextromethorphan (S. 644)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Monitored legislation concerning promotion of generic drug use and medicaid Drug Shortages, FDA regulations Legislation affecting settlements between generic and all brand companiesH.R. - 486 Stop Tampering with Prescription Drugs S.348 - The Prescription Drug Abuse and Prevention Act Issues concerning Rx Abuse

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, White House Office

Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) (H.R. 3204) (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277); Hydrocodone Rescheduling (H.R. 1285, S. 621) Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715)

Client expense: $279,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness ActSpecialty drug costs

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR.672 Prescription Drug Abuse Prevention and Treatment Act of 2013 S. 348 Prescription Drug Abuse Prevention and Treatment Act of 2013 Prescription drug abuse S. 1365 Part D Beneficiary Appeals Fairness Actspecialty drug costs

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348

Client expense: $790,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageImportation of prescription drugs Drug Abuse (S. 348, H.R. 1285, S. 621, S. 644, S. 1277) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R.1919, H.R. 2186) Prescription Drug Monitoring Program Counterfeit Drugs Drug Take Back (S. 1089)

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S. 348/H.R. 672: Prescription Drug Abuse Prevention and Treatment Act

Client expense: $290,000 · Firm income: Not reported

Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) (H.R. 3204); Prescription Drug Monitoring Programs; Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644), Prescription Drug Abuse (S. 1277); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs

Client expense: $285,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Safe Prescribing Act (HR 1285/S 621) Stop Oxy Abuse Act (HR 1366) Prescription Drug Abuse Prevention and Treatment Act (HR 672/S 348) Access to Substance Abuse Treatment Act of 2013 (HR 2130)

Client expense: $29,680 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Monitored legislation concerning promotion of generic drug use and medicaid Drug Shortages, FDA regulations Legislation affecting settlements between generic and all brand companiesH.R. - 486 Stop Tampering with Prescription Drugs S.348 - The Prescription Drug Abuse and Prevention Act Issues concerning Rx Abuse

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

**see addendum pageImportation of prescription drugs Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644), Prescription Drug Abuse (S. 1277) Drug Shortages - Gray Market (H.R. 1958) Rx Pedigree (S. 959, S. 957, H.R. 1919) (H.R. 2186) Prescription Drug Monitoring Program Counterfeit Drugs

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Opioid and prescription drug abuse - HR 672, Prescription Drug Abuse Prevention and Treatment Act of 2013; S 348, Prescription Drug Abuse Prevention and Treatment Act of 2013.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348

Client expense: $310,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Rx Pedigree (S. 959, S. 957, H.R. 1919, H.R. 2186); Prescription Drug Monitoring Programs; Drug Abuse (S. 348); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Prescription Drug Abuse (S. 1277); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs

Client expense: $358,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Monitored legislation concerning promotion of generic drug use and medicaid Drug Shortages, FDA regulations Legislation affecting settlements between generic and all brand companiesH.R. - 486 Stop Tampering with Prescription Drugs S.348 - The Prescription Drug Abuse and Prevention Act

Client expense: Not reported · Firm income: $60,000

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

S. 348/H.R. 672: Prescription Drug Abuse Prevention and Treatment Act

Client expense: $290,000 · Firm income: Not reported

Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of

Safe Prescribing Act (HR 1285/S 621) Stop Oxy Abuse Act (HR 1366) Prescription Drug Abuse Prevention and Treatment Act (HR 672/S 348) Access to Substance Abuse Treatment Act of 2013 (HR 2130)

Client expense: $124,160 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348

Client expense: $441,590 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE

S. 348/H.R. 672: Prescription Drug Abuse Prevention and Treatment Act

Client expense: $230,000 · Firm income: Not reported

Government targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), SENATE, Treasury, Dept of

**see addendum pageImportation of prescription drugs Drug Abuse (S. 348), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644) Drug Shortages Rx Pedigree Prescription Drug Monitoring Program Counterfeit Drugs ***, no specific bills, supply chain integrity, prescription drug abuse

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Monitored legislation concerning promotion of generic drug use and medicaid Drug Shortages, FDA regulations Legislation affecting settlements between generic and all brand companiesH.R. - 486 Stop Tampering with Prescription Drugs S.348 - The Prescription Drug Abuse and Prevention Act

Client expense: Not reported · Firm income: $60,000

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

Safe Prescribing Act (HR 1285/S 621) Stop Oxy Abuse Act (HR 1366) Prescription Drug Abuse Prevention and Treatment Act (HR 672/S 348)

Client expense: $27,073 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE